Superdisintegrants Market Research Report by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, and Others), Formulation (Tablets, Capsules), Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, and Others), and Region (America, Europe, APAC, Middle East & Africa)–Global Forecast to 2027
ID: MRFR/Pharma/5200-HCR | August 2022 | Region: Global | 100 Pages
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Superdisintegrants Market, by Type
6.1 Introduction
6.2 Synthetic Superdisintegrants
6.2.1 Crospovidone
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Modified Starch
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.3 Modified Cellulose
6.2.3.1 Croscarmellose Sodium
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.3.2 Low-Substituted Hydroxypropyl Cellulose
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.4 Calcium Silicates
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.5 Ion Exchange Resins
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Natural Superdisintegrants
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Other Superdisintegrants
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Superdisintegrants Market, by Formulation
7.1 Tablets
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2 Capsules
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Superdisintegrants Market, By Therapeutic Area
8.1 Neurological Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2 Gastrointestinal Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3 Oncology
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.4 Inflammatory Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.5 Infectious Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.6 Cardiovascular Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.7 Hematological Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 9. Global Superdisintegrants Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 BASF SE
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Ashland Global Holdings Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 DowDuPont Inc.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Roquette Freres
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 DFE Pharma
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 JRS Pharma
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Asahi Kasei Corporation
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Merck KGaA
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Corel Pharma Chem
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Avantor Performance Materials, LLC
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Superdisintegrants Market Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Superdisintegrants Market Synopsis, 2020–2027
Table 2 Global Superdisintegrants Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Superdisintegrants Market, by Region, 2020–2027 (USD Million)
Table 4 Global Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 5 Global Superdisintegrants, by Formulation, 2020–2027 (USD Million)
Table 6 Global Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 7 North America: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 8 North America: Superdisintegrants, by Formulation, 2020–2027 (USD Million)
Table 9 North America: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 10 US: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 11 US: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 12 US: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 13 Canada: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 14 Canada: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 15 Canada: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 16 South America: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 17 South America: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 18 South America: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 19 Europe: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 20 Europe: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 21 Europe: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 22 Western Europe: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 23 Western Europe: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 24 Western Europe: Superdisintegrants Market, by Therapeutic Area, 2020–2027(USD Million)
Table 25 Eastern Europe: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 26 Eastern Europe: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 27 Eastern Europe: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 28 Asia-Pacific: Superdisintegrants Market, by Type, 2020–2027 (USD Million)
Table 29 Asia-Pacific: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 30 Asia-Pacific: Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
Table 31 Middle East & Africa: Superdisintegrants by Market, by Type, 2020–2027 (USD Million)
Table 32 Middle East & Africa: Superdisintegrants Market, by Formulation, 2020–2027 (USD Million)
Table 33 Middle East & Africa Superdisintegrants Market, by Therapeutic Area, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Superdisintegrants Market
Figure 3 Segmentation Market Dynamics for Global Superdisintegrants Market
Figure 4 Global Superdisintegrants Market Share, by Type, 2020
Figure 5 Global Superdisintegrants Market Share, by Formulation, 2020
Figure 6 Global Superdisintegrants Market Share, by Therapeutic Area, 2020
Figure 7 Global Superdisintegrants Market Share, by Region, 2020
Figure 8 North America: Superdisintegrants Market Share, by Country, 2020
Figure 9 Europe: Superdisintegrants Market Share, by Country, 2020
Figure 10 Asia-Pacific: Superdisintegrants Market Share, by Country, 2020
Figure 11 Middle East & Africa: Superdisintegrants Market Share, by Country, 2020
Figure 12 Global Superdisintegrants Market: Company Share Analysis, 2020 (%)
Figure 13 BASF SE: Key Financials
Figure 14 BASF SE: Segmental Revenue
Figure 15 BASF SE: Geographical Revenue
Figure 16 Ashland Global Holdings Inc.: Key Financials
Figure 17 Ashland Global Holdings Inc.: Segmental Revenue
Figure 18 Ashland Global Holdings Inc.: Geographical Revenue
Figure 19 DowDuPont Inc.: Key Financials
Figure 20 DowDuPont Inc.: Segmental Revenue
Figure 21 DowDuPont Inc.: Geographical Revenue
Figure 22 Roquette Freres: Key Financials
Figure 23 Roquette Freres: Segmental Revenue
Figure 24 Roquette Freres: Geographical Revenue
Figure 25 DFE Pharma: Key Financials
Figure 26 DFE Pharma: Segmental Revenue
Figure 27 DFE Pharma: Geographical Revenue
Figure 28 JRS Pharma: Key Financials
Figure 29 JRS Pharma: Segmental Revenue
Figure 30 JRS Pharma: Geographical Revenue
Figure 31 Asahi Kasei Corporation: Key Financials
Figure 32 Asahi Kasei Corporation: Segmental Revenue
Figure 33 Asahi Kasei Corporation: Geographical Revenue
Figure 34 Merck KGaA: Key Financials
Figure 35 Merck KGaA: Segmental Revenue
Figure 36 Merck KGaA: Geographical Revenue
Figure 37 Corel Pharma Chem: Key Financials
Figure 38 Corel Pharma Chem: Segmental Revenue
Figure 39 Corel Pharma Chem: Geographical Revenue
Figure 40 Avantor Performance Materials, LLC: Key Financials
Figure 41 Avantor Performance Materials, LLC: Segmental Revenue
Figure 42 Avantor Performance Materials, LLC: Geographical Revenue
Superdisintegrants Market
Superdisintegrants Market is anticipated to reach USD 720.35 Million at CAGR of 8.1% during the forecast 2022-2030
$720.35 Million
Market Size
8.1%
CAGR
North America
Dominating Region
2022-2030
Forecast Period
Segmentation
Key Players
- Asahi Kasei Corporation
- DFE Pharma
- JRS Pharma
- Corel Pharma Chem
- Ashland Global Holdings Inc.
- BASF SE
- Roquette Freres
- DowDuPont Inc.
- Merck KGaA
- Avantor Performance Materials
- LLC
Drivers
- Rising populations of both geriatric patients and pediatric patients
- Rise in the manufacturing of generic drugs
Superdisintegrants Market Overview
The Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 7.9% during the forecast period. Disintegrants are chemicals added to medicine formulas to aid in the disintegration of capsules and tablets into easily dissolved particles. This is important for the rapid absorption of the medicine, which improves its potency. Superdisintegrants are disintegrants with small modifications that are more efficient than their standard equivalents. The pharmaceutical industry is rapidly expanding and has become an important aspect of the healthcare industry. This is mostly attributable to an increase in the number of geriatric and pediatric patients. Patients in this population benefit from super disintegrants because the tablets are simpler to swallow. These demographics are projected to drive market expansion.
Furthermore, generic medications are in high demand since patents on some major prescription names have begun to expire, opening the pharmaceutical sector to increased competition and a rise in generic drug manufacturing, fuelling demand for superdisintegrants. Emerging markets provide enormous opportunities because their healthcare sectors are rapidly expanding. Furthermore, huge patient populations in these countries are projected to drive up the demand for fast-acting drugs. Market companies are likely to establish themselves in the region to take advantage of emerging market prospects.
Superdisintegrants Market Report Overview
MRFR's global superdisintegrants market report contains an entire historical analysis along with current trends to assemble a panoramic view of the market. Drivers, restraints, threats, and opportunities have been expounded in the report along with projections for the future of the market over the forecast period from 2018 to 2023. All parameters relevant to the global superdisintegrants market have been taken into account including the various parts of the market which have been segmented on the basis of types, formulation, therapeutic area, and region. Moreover, various key players operating in the market's competitive landscape have been profiled to provide an impact analysis of various vital growth strategies.
Players Covered
Prominent superdisintegrants market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC
Research Methodology
Market Research Future's market report on the surface disinfectant market has employed various proprietary research methods to ascertain the forecast of the market. Primary data sources such as personal one-on-one interviews with marketing directors, and other important executives, thus providing a deeper insight into industry performance and expectations of the market. Meanwhile, secondary sources of data which refer to both internal and external sources such as customer feedback, analysis of marketing activities, industry publications, annual reports, and others are useful for a full commercial study of the global surface disinfectant market. Moreover, MRFR's data analysts use both top-down and bottom-up approaches for the estimation and validation of Superdisintegrants Market size. All data is processed, analyzed and consolidated into brief palatable reports which include intelligent observations regarding various important Superdisintegrants Market factors.
Recent Development
Roquette built a new Pharmaceutical R&D and Customer Technical Service (CTS) in Biopolis (Singapore) in October 2017 for the development of new medicines, new applications for current products, and preclinical research. Roquette's Asia Pacific headquarters is located here, and it concentrates on food, nutrition, and pharmaceutical products.
DFE Pharma's supply chain of pharmaceutical excipients was effectively streamlined in July 2018. Furthermore, the company has made significant investments in factory capacity development to address the global demand for high-quality excipients such as pharmaceutical grade Lactose and Microcrystalline Cellulose (MCC).
Ashland launched a new pharmaceutical excipient factory in Nanjing, China, in October 2016, to create excipients for the Asian market. This laboratory provides highly functioning excipient technology to oral pharmaceutical makers as well as tailor-made formulation solutions.
Superdisintegrants Market Segmentation
Type
- Synthetic Superdisintegrants
- Natural Superdisintegrants
- Other Superdisintegrants
Formulation
- Tablets
- Capsules
Therapeutic Area
- Neurological Diseases
- Gastrointestinal Diseases
- Oncology
- Inflammatory Diseases
- Cardiovascular Diseases
- Hematological Diseases
- Infectious Diseases
Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 576.2 Million |
| CAGR | 7.9% (2018 to 2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type, Formulation, Therapeutic Area, Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC |
| Key Market Opportunities | Joint ventures, strategic alliances, mergers and acquisitions and new product developments |
| Key Market Drivers |
|
